chemotherapy

You have access
Factor Analysis of Intraoperative Bleeding Loss and its Impact on Prognosis in Breast Cancer
KOJI TAKADA, SHINICHIRO KASHIWAGI, NOZOMI IIMORI, RIKA KOUHASHI, AKIMICHI YABUMOTO, WATARU GOTO, YUKA ASANO, YUKIE TAUCHI, KANA OGISAWA, TAMAMI MORISAKI, MASATSUNE SHIBUTANI, HIROAKI TANAKA and KIYOSHI MAEDA

Anticancer Research January 2023, 43 (1) 191-200; DOI: https://doi.org/10.21873/anticanres.16149
You have access
Differences in Toxicity Between Ashkenazi and Sephardic Jews With Colon Cancer Treated With Adjuvant Chemotherapy: A Prospective Study
BARUCH BRENNER, YAEL STERN, NOA GORDON, TZIPORA FUKS, TAL GRANOT, JULIET DREYER and AARON SULKES

Anticancer Research January 2023, 43 (1) 239-245; DOI: https://doi.org/10.21873/anticanres.16155
You have access
Effect of Secondary Prophylactic G-CSF on the Occurrence of Febrile Neutropenia in Breast Cancer
KANAKO SUZUKI, SHINSUKE SASADA, YURI KIMURA, AKIKO EMI, TAKAYUKI KADOYA and MORIHITO OKADA

Anticancer Research December 2022, 42 (12) 5945-5949; DOI: https://doi.org/10.21873/anticanres.16104
You have access
First-Line Gemcitabine, Nab-Paclitaxel, and Oxaliplatin Chemotherapy With Itraconazole in Patients With Metastatic Pancreatic Cancer: A Single Institution Experience
MIYUKI SAWASAKI, HIROSHI TSUBAMOTO, AYAKO SUGIHARA, SHINICHI IKUTA, YOSHIYUKI SAKAI, YUKIO OSAKI and TAKASHI SONODA

Anticancer Research December 2022, 42 (12) 6063-6069; DOI: https://doi.org/10.21873/anticanres.16118
You have access
Initial Experience With Atezolizumab Plus Bevacizumab for Unresectable Hepatocellular Carcinoma: A Real-world Retrospective Study
SOICHI TAKEDA, TADASHI NAMISAKI, YUKI TSUJI, YUKI FUJIMOTO, KOJI MURATA, MASAHIDE ENOMOTO, YUKIHISA FUJINAGA, NORIHISA NISHIMURA, KOH KITAGAWA, HIROAKI TAKAYA, KOSUKE KAJI, TAKASHI INOUE, HIDETO KAWARATANI, TAKEMI AKAHANE, AKIRA MITORO and HITOSHI YOSHIJI

Anticancer Research November 2022, 42 (11) 5465-5473; DOI: https://doi.org/10.21873/anticanres.16051
You have access
Neoadjuvant Therapy for Patients With Non-small Cell Lung Cancer Complicated With Chest Wall Invasion
KEIYU SATO, SHOTA NAKAMURA, YUKA KADOMATSU, HARUSHI UENO, TAKETO KATO, NAOKI OZEKI, KOICHI FUKUMOTO and TOYOFUMI FENGSHI CHEN-YOSHIKAWA

Anticancer Research November 2022, 42 (11) 5539-5546; DOI: https://doi.org/10.21873/anticanres.16059
You have access
Neoadjuvant Modified Short-course Radiotherapy for Stage IV Rectal Cancer
HIROSHI DOI, MASAYUKI FUJIWARA, NAOHITO BEPPU, HIROYUKI YOKOYAMA, SHOGO HARUI, AYAKO SUGIHARA, HIDENORI YANAGI, YOSHIO HISHIKAWA, NAOKI YAMANAKA and NORIHIKO KAMIKONYA

Anticancer Research November 2022, 42 (11) 5587-5595; DOI: https://doi.org/10.21873/anticanres.16066
Open Access
Retrospective Analysis of Treatment Pathways in Patients With BRAF^V600E-mutant Metastatic Colorectal Carcinoma – MORSE^CRC
ARMIN GERGER, WOLFGANG EISTERER, STEFAN FUXIUS, SARA BASTIAN, DIETER KOEBERLE, MANFRED WELSLAU, DILARA AKHOUNDOVA SANOYAN, CHRISTIAN MAAS, JENS UHLIG, KLAUS FENCHEL, RICHARD GREIL, EYCK VON DER HEYDE, GAËLLE RHYNER AGOCS, RUDOLF WEIDE, MONIKA SCHWAGER, FRANK REICHENBACH, DOMINIK PAUL MODEST and RALPH FRITSCH

Anticancer Research October 2022, 42 (10) 4773-4785; DOI: https://doi.org/10.21873/anticanres.15982
You have access
Leaky Gut and Severe Adverse Events in Advanced Hepatocellular Carcinoma Treated With Lenvatinib
YUKI FUJIMOTO, TADASHI NAMISAKI, SOICHI TAKEDA, KOJI MURATA, MASAHIDE ENOMOTO, HIROAKI TAKAYA, YUKI TSUJI, YUKIHISA FUJINAGA, YASUHIKO SAWADA, NORIHISA NISHIMURA, KOH KITAGAWA, KOSUKE KAJI, TAKASHI INOUE, HIDETO KAWARATANI, KEI MORIYA, TAKEMI AKAHANE, AKIRA MITORO and HITOSHI YOSHIJI

Anticancer Research October 2022, 42 (10) 4895-4905; DOI: https://doi.org/10.21873/anticanres.15995
You have access
Comparison of Survival Outcomes Based on Pre-treatment Pleural Effusion in Advanced Epithelial Ovarian Cancer
JUHUN LEE and DAE GY HONG

Anticancer Research October 2022, 42 (10) 4937-4943; DOI: https://doi.org/10.21873/anticanres.16000

Main menu

User menu

Search

chemotherapy

Pages